10.40 | 7.40 – Expertise Panelist Discussion: The Additive Role of CTCs & ctDNA in Your Clinical Development Strategy
Time: 10:40 am
day: Day Two
Details:
- Complementing your biomarker evaluation with CTCs
- Comprehensive cancer profiling: CTCs and ctDNA
- Banking the remnant plasma and slides for future analysis
